Latest / Annapolis News Today | 2 Min News | The Daily News Now!
mRNA Cancer Vaccine Shows Promise | Annapolis News
Merck and Moderna just dropped electrifying Phase Three trial results for a personalized mRNA cancer vaccine designed to stop melanoma from returning after surgery—paired with Keytruda, it’s sparking huge excitement in the oncology world. This breakthrough leverages the same mRNA tech that powered COVID vaccines, but now tailored to each patient’s tumor by coding immune-activating instructions directly into RNA. Experts say it could revolutionize cancer treatment across multiple cancers like bladder and lung. While scaling production and cost remain hurdles, innovations like distributed…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.